July 7, 2025 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labeling for the FARAPULSE Pulsed Field Ablation (PFA) System. The updated labeling now includes approval for the system in the treatment of drug refractory, symptomatic persistent atrial fibrillation (AF), an arrythmia in which the heart beats abnormally for at least seven days.

July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including 'OFF MED’ and 'ON MED’ studies). The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo.

Cleerly, a leader in cardiovascular imaging, today announced the promotions of two key executives to expanded leadership roles. Dr. Udo Hoffmann, MD, MPH, has been promoted to Chief Medical, Scientific and AI Officer, while Amit Relia has been named Chief Regulatory Officer. These strategic promotions position Cleerly for accelerated growth and expansion while reinforcing the company's commitment to scientific rigor and advancement of cardiovascular care through technological excellence.

Every second counts when someone is having a stroke and immediate care can mean the difference between life and death. While there is widespread consensus on the importance of identification and immediate care for acute stroke patients, a gap remains in the critical role of post-stroke care and secondary stroke prevention strategies. These critical matters impact the care of the more than 795,000 people in the United States who experience a stroke every year.

Merge by Merative empowers healthcare organizations with advanced medical imaging solutions to enhance workflows, optimize care delivery, and improve patient outcomes. Trusted by 6 of the 10 largest U.S. health systems and built on a cloud-native foundation, Merge’s portfolio includes solutions for Vendor-Neutral Archive (VNA), PACS, Workflow Orchestration, Cardiology and hemodynamics, and digital pathology. Learn more at merative.com/merge-imaging.

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling one-year results from the India Clinical Trial of the TRIA Mitral Valve, showing a good safety profile, sustained hemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicenter clinical study of a polymer heart valve worldwide.

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses reveal that cardiac arrhythmias are common and often occur early in people with type 2 diabetes (T2D) — especially those who also have chronic kidney disease (CKD).

June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment in Philips’ advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new interventional suites will support critical health needs within the community including complex cardiovascular intervention, active stroke treatment, oncology therapies and care for other prevalent health conditions.

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging solutions will be on display at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana.


Despite advancements in ventricular arrhythmia (VA) screening, numerous high-profile athlete cases have highlighted the need for improved detection and management. A new study presented at Heart Rhythm 2025 in April evaluated the connection between complex VA patterns in athletes and underlying structural heart disease, offering critical insights into the prognostic value of both non-invasive and invasive assessments in athletes with complex VAs.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now